Ropharma (RPH.RO), one of the top five pharmaceutical groups in Romania, with integrated operations from pharmaceutical production to distribution, pharmacies and hospital, announced RON1.1 million net profit in the first quarter of 2025, slightly up from the RON1 million in the first quarter of 2024.
Pharmaceutical producer Zentiva (SCD.RO) posted RON55.2 million net profit in the first quarter of 2025, 25.5% lower year-on-year, while revenue stood at RON271.3 million, 1.9% higher, according to ZF’s calculations based on the data in the quarterly financial report.